Developing a PPI inhibitor-based therapy for STXBP1 haploinsufficiency-associated epileptic disorders

Shobbir Hussain1

  • 1Wellcome Trust - Medical Research Council Cambridge Stem Cell Institute, University of Cambridge Cambridge, UK ; Department of Physiology, Development and Neuroscience, University of Cambridge Cambridge, UK.

Abstract

No abstract available in PubMed .

Related Concept Videos